Drug news
Arikase trials for use in Cystic Fibrosis are placed on hold by FDA
Phase III clinical trials of Arikace (liposomal amikacin for inhalation) from Insmed for cystic fibrosis have been placed on hold by the FDA due to cases of carcinogenicity.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.